174 related articles for article (PubMed ID: 25628948)
1. Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.
Wang W; Ma XP; Shi Z; Zhang P; Ding DL; Huang HX; Saiyin HG; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Zheng SL; Yu L; Xu J; Jiang DK
Am J Cancer Res; 2015; 5(1):396-410. PubMed ID: 25628948
[TBL] [Abstract][Full Text] [Related]
2. NRP-1 and KDR polymorphisms are associated with survival time in patients with advanced gastric cancer.
Zhuo YJ; Shi Y; Wu T
Oncol Lett; 2019 Nov; 18(5):4629-4638. PubMed ID: 31611971
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in apoptosis-related genes and the prognosis of hepatocellular carcinoma.
Yu GP; Xiao QY; Shi ZQ; Tang LS; Ma XP; Zhang LY; Chen HT; Wang WJ; Zhang PY; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu HJ; Sun JL; Zheng SL; Xu JF; Yu L; Jiang DK
Am J Cancer Res; 2015; 5(10):3249-59. PubMed ID: 26693075
[TBL] [Abstract][Full Text] [Related]
4. Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma.
Escudier B; Rini BI; Motzer RJ; Tarazi J; Kim S; Huang X; Rosbrook B; English PA; Loomis AK; Williams JA
Clin Genitourin Cancer; 2015 Aug; 13(4):328-337.e3. PubMed ID: 25816720
[TBL] [Abstract][Full Text] [Related]
5. EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy.
Su NW; Leu YS; Lee JC; Liu CJ; Cheng CY; Lin JS; Chen YJ; Chen CK; Fang IC; Hsieh RK; Chang YF
Onco Targets Ther; 2014; 7():2197-204. PubMed ID: 25506224
[TBL] [Abstract][Full Text] [Related]
6. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
[TBL] [Abstract][Full Text] [Related]
7. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
[TBL] [Abstract][Full Text] [Related]
8. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
10. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
[TBL] [Abstract][Full Text] [Related]
11. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
13. The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.
Lee S; Kang HG; Choi JE; Lee JH; Kang HJ; Baek SA; Lee E; Seok Y; Lee WK; Lee SY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Park JY
J Korean Med Sci; 2016 Nov; 31(11):1735-1741. PubMed ID: 27709850
[TBL] [Abstract][Full Text] [Related]
14. Potentially functional variants of
Huang Q; Liu Y; Qiu M; Lin Q; Wei X; Zhou Z; Liang X; Li R; Chen W; Zhou X; Yu H
Front Oncol; 2022; 12():990160. PubMed ID: 36119471
[TBL] [Abstract][Full Text] [Related]
15. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma.
Herman M; Lok BH; Gallinger S; Dawson L; Kim R; Cheng D; Paton T; Bucur R; Patel D; Fazelzad R; Hueniken K; Liu G
Transl Gastroenterol Hepatol; 2023; 8():32. PubMed ID: 38021355
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
19. [Influence of polymorphisms of VEGFR2 on clinical outcomes and safety of advanced non-small-cell lung cancer treated by first line Bevacizumab plus chemotherapy regimens].
Fan HJ; Yuan J; Wu JJ; Jia YX; Ma YH; Li XY
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):99-104. PubMed ID: 30669746
[No Abstract] [Full Text] [Related]
20. Polymorphisms in TRAIL predict long-term survival and extrahepatic recurrence following initial hepatectomy for hepatocellular carcinoma.
Imaoka Y; Ohira M; Yano T; Nakano R; Tanimine N; Shimizu S; Kuroda S; Tahara H; Kobayashi T; Ohdan H
J Hepatobiliary Pancreat Sci; 2018 Aug; 25(8):370-376. PubMed ID: 30051596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
